Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F W Cremer

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
British Journal of Cancer|September 14, 2006
Preoperative elevation of serum C--reactive protein is predictive for prognosis in myeloma bone disease after surgeryA Zahlten-Hinguranage, H Goldschmidt, F W Cremer, et al.
British Journal of Haematology|March 2, 1999
Autografting with CD34+ peripheral blood stem cells: retained engraftment capability and reduced tumour cell contentM T Voso, S Hohaus, M Moos, et al.
Annals of Hematology|March 22, 2002
Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantationC Gemmel, F W Cremer, M Weis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2005
Molecular monitoring of tumour load kinetics predicts disease progression after non-myeloablative allogeneic stem cell transplantation in multiple myelomaM S Raab, F W Cremer, I N Breitkreutz, et al.
Bone Marrow Transplantation|September 25, 2007
Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14)M Hundemer, U Klein, D Hose, et al.
Oncogene|May 30, 2006
Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myelomaK Mahtouk, F W Cremer, T Rème, et al.
Leukemia|March 23, 2007
Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yieldI Breitkreutz, H M Lokhorst, M S Raab, et al.
British Journal of Cancer|March 6, 2015
Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromesC P Kratz, L Franke, H Peters, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
British Journal of Cancer|September 14, 2006
Preoperative elevation of serum C--reactive protein is predictive for prognosis in myeloma bone disease after surgeryA Zahlten-Hinguranage, H Goldschmidt, F W Cremer, et al.
British Journal of Haematology|March 2, 1999
Autografting with CD34+ peripheral blood stem cells: retained engraftment capability and reduced tumour cell contentM T Voso, S Hohaus, M Moos, et al.
Annals of Hematology|March 22, 2002
Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantationC Gemmel, F W Cremer, M Weis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2005
Molecular monitoring of tumour load kinetics predicts disease progression after non-myeloablative allogeneic stem cell transplantation in multiple myelomaM S Raab, F W Cremer, I N Breitkreutz, et al.
Bone Marrow Transplantation|September 25, 2007
Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14)M Hundemer, U Klein, D Hose, et al.
Oncogene|May 30, 2006
Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myelomaK Mahtouk, F W Cremer, T Rème, et al.
Leukemia|March 23, 2007
Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yieldI Breitkreutz, H M Lokhorst, M S Raab, et al.
British Journal of Cancer|March 6, 2015
Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromesC P Kratz, L Franke, H Peters, et al.
Pageof 2